Table 4

Evaluation of yield of T.Spot and tuberculin skin test (TST) in patients categorised as low risk

Number of patients identified for chemoprophylaxis (%)Number of patients missed (would have been identified via other methods) (%)Sensitivity versus double testing combination (%)
T.Spot +ve21 (19.1)18 (16.4)53.8 (37.2–69.9)
TST +ve26 (23.6)13 (11.8)66.7 (49.8–80.9)
T.Spot and/or TST +ve39 (35.5)
  • Data shown as n (% of low risk sub-group 110) or sensitivity (95% CI).